ImportRefusal LogoImportRefusal

Bioquifar Pharmaceutica Sa Cr

⚠️ Moderate Risk

FEI: 3011572663 • Bogota, Cundinamarca • COLOMBIA

FEI

FEI Number

3011572663

📍

Location

Bogota, Cundinamarca

🇨🇴

Country

COLOMBIA
🏢

Address

Carrera 37a 25-52, , Bogota, Cundinamarca, Colombia

Moderate Risk

FDA Import Risk Assessment

43.5
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

3
Total Refusals
1
Unique Violations
7/8/2020
Latest Refusal
10/14/2016
Earliest Refusal

Score Breakdown

Violation Severity
90.0×40%
Refusal Volume
22.3×30%
Recency
0.0×20%
Frequency
8.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
7/8/2020
61JCY08ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/15/2019
66SDY51TADALAFIL
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/14/2016
61WCA45FLUCONAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is Bioquifar Pharmaceutica Sa Cr's FDA import refusal history?

Bioquifar Pharmaceutica Sa Cr (FEI: 3011572663) has 3 FDA import refusal record(s) in our database, spanning from 10/14/2016 to 7/8/2020.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Bioquifar Pharmaceutica Sa Cr's FEI number is 3011572663.

What types of violations has Bioquifar Pharmaceutica Sa Cr received?

Bioquifar Pharmaceutica Sa Cr has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Bioquifar Pharmaceutica Sa Cr come from?

All FDA import refusal data for Bioquifar Pharmaceutica Sa Cr is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.